Diabetology

At IRCCS ISMETT, we provide specialized diagnosis and treatment for patients with diabetes mellitus who are awaiting or have undergone transplantation. The Diabetology Service evaluates patients for pancreas or pancreatic islet transplantation and provides advanced therapies and long-term follow-up care. Using state-of-the-art medications and diabetes management technologies, the Service delivers personalized care across the full spectrum of treatment options, including pancreas-alone transplantation and simultaneous pancreas-kidney transplantation.

Candidates for pancreas transplantation undergo a comprehensive multidisciplinary medical and surgical evaluation and receive coordinated support throughout the preoperative pathway and post-transplant follow-up. Patient care is based on a multidisciplinary approach involving the Hepatology Unit, Dietetics Service, Clinical Psychology Service, and other specialties. Patients at high cardiovascular risk or with heart failure are jointly managed with the Cardiology Unit.

The Diabetology Service also conducts clinical research in diabetes and metabolism by developing experimental protocols and participating in multicenter studies.

Its activities benefit from the expertise of Dr. Camillo Ricordi, Chairman of the IRCCS ISMETT Board of Directors and Director Emeritus of the Diabetes Research Institute (DRI) at the University of Miami, one of the world’s leading research centers in diabetes and pancreatic islet transplantation.